Information on Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy
Basic details
Name: Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy | Acronym:
Alt. names:
Gene: CD59 | MOI: Autosomal recessive | Mechanism of action:
No. of cases in DB: 0 | First reported in: 1992
Last updated on: 2023-02-28 16:41:18 by
Description
Surveillance to allow early diagnosis and treatment of manifestations including hemolytic anemia, as well as thrombotic risk, may be beneficial; Immunosuppressive treatment has been reported as resulting in clinical improvement. Refs. PMIDs: 1691667; 1699124; 1382994; 21707954; 23149847
Management
Description of management option has not been reviewed yet.
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
0 reported cases added to GenIA
| SubjectID | Sex | Fam.ID | AD | AFM | Validity | Country | Population | Reference & Pub.code |
|---|
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).
Summary of clinical findings
[Considering only Definitive and Possible cases]
| Rank | Clinical term | Present | Absent | Unreported |
|---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
| Treatment ⓘ | Responses & clinical indications |
|---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.